CHAPEL HILL, N.C.--(BUSINESS WIRE)--Oct. 13, 2005--POZEN Inc.
(NASDAQ: POZN), announced today that it will release third quarter
results on October 27, 2005, before the market opens.
The announcement will be followed by a live webcast at 11:00 a.m.
Eastern Time of a discussion by POZEN management of the earnings and
business results. The webcast can be accessed on POZEN's website at
www.pozen.com and will be archived and available for replay. The third
quarter earnings release can be accessed in the News section of
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. Since its
inception, POZEN has focused its efforts primarily on the development
of pharmaceutical products for the treatment of migraine. POZEN is
also exploring the development of product candidates in other
pain-related therapeutic areas. POZEN has development and a
commercialization alliance with GlaxoSmithKline. The company's common
stock is traded on The Nasdaq Stock Market under the symbol "POZN".
For detailed company information, including copies of this and other
press releases, see POZEN's website: www.pozen.com.
Bill Hodges, 919-913-1030
Chief Financial Officer
Fran Barsky, 919-913-1044
Director, Investor Relations
SOURCE: POZEN Inc.